Our Policies
News

Newsletter

15 de April de 2021

ANVISA opens a Public Consultation to improve the reliance on foreign regulatory authorities’ opinions

ANVISA’s Board of Directors opened a Public Consultation (“PC 1,039/2021”), available to contributions between 04/15/2021 and 06/15/2021, to discuss a proposed regulation to establish criteria for ANVISA to rely on the analysis carried out by equivalent foreign regulatory authorities for the purposes of marketing approval of products, optimizing the current procedures.
The optimized analysis consists of a procedure that uses a regulatory document issued by an equivalent foreign regulatory authority to streamline the efficiency of Anvisa’s assessment, avoiding duplication of efforts.
The proposal establishes that the equivalent foreign regulatory authorities must have the same standard of health protection and must adopt international standards and guidelines similar to those adopted by ANVISA, including good regulatory practices. 
In addition, authorities that are part of a cooperation program or association integrated by ANVISA may be considered equivalent depending on the category of the product or process. In this case, the foreign regulatory authority would be considered equivalent by a decision to be rendered by ANVISA’s Board of Directors and the updated list of the equivalent authorities would be available on ANVISA's website.  
The main goals of the proposal are:
 
(i) increase product availability through predictability and legal certainty to companies,
(ii) savings in time and financial resources and,
(iii) more strategic use of ANVISA’s resources.
Last but not least, the proposal also presents provisions to stress ANVISA’s autonomy despite the reliance within the optimized procedure. 
For more information, please do not hesitate to contact our team via email: regulatorio@kasznarleonardos.com. 
 
Back

Last related news

13 de November de 2025

ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products

The National Health Surveillance Agency (Anvisa) published on Monday, November 10, 2025, the Collegiate Board Resolution (RDC) No. 997/2025, which institutes exceptional … ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products

  • Kasznar Leonardos
    • Ler notícia

    4 de November de 2025

    ANVISA Publishes New Proposal for Review of the Regulation on General Labeling of Packaged Foods: Public Consultation No. 1357/2025

    The proposal for reviewing the regulation concerning the general labeling of packaged foods (including beverages, ingredients, additives, and processing aids) was published … ANVISA Publishes New Proposal for Review of the Regulation on General Labeling of Packaged Foods: Public Consultation No. 1357/2025

    Ler notícia

    20 de October de 2025

    Brazil enacts the ECA Digital: a landmark law for children’s rights in the Digital Age

    Last month, Brazil took a major step toward regulating the digital environment for children and adolescents with the enactment of the ECA … Brazil enacts the ECA Digital: a landmark law for children’s rights in the Digital Age

    Ler notícia

    Check out our Social Responsability and Sustainability projects

    Meet our complete team